Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2009
10/29/2009WO2009129726A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
10/29/2009WO2009109911A8 Methods of treating chronic pain
10/29/2009WO2009105504A3 Functionally selective alpha2c adrenoreceptor agonists
10/29/2009WO2009103932A8 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain
10/29/2009WO2009041799A9 Pharmaceutical composition combining diacerein and chondroitin sulphate and use thereof in the treatment of osteoarthritis and related diseases
10/29/2009WO2009035951A3 Soluble epoxide hydrolase inhibitors
10/29/2009WO2008122119A8 Perfluoroketone compounds and uses thereof
10/29/2009WO2007146602A8 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
10/29/2009US20090270616 Aryl sulfonamides
10/29/2009US20090270491 Modulation of tudor-sn expression
10/29/2009US20090270458 Method of treating of demyelinating diseases or conditions
10/29/2009US20090270455 Therapeutic agent for intestinal diseases and visceral pain
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270441 Macrolides
10/29/2009US20090270426 P13 Kinase Antagonists
10/29/2009US20090270403 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
10/29/2009US20090270399 Novel pyridazine derivatives and medicines containing the same as effective ingredients
10/29/2009US20090270388 Fused azole-pyrimidine derivatives
10/29/2009US20090270382 Soluble epoxide hydrolase inhibitors
10/29/2009US20090270368 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof
10/29/2009US20090270365 such as N-(2,4-dimethyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2-(piperidin-1-ylmethyl)biphenyl-4-carboxamide, having vanilloid receptor 1 antagonistic activity, used as analgesics
10/29/2009US20090270355 Compounds
10/29/2009US20090269840 Kinase insert domain-containing receptor (KDR) specific immunoglobulin for monitoring tumor angiogenesis
10/29/2009US20090269421 Coating material
10/29/2009US20090269415 Novel therapeutic agent derived from marine organism
10/29/2009US20090269410 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
10/29/2009US20090269303 Method for treating or preventing conditions by elevation of the adenosine level in an individual
10/29/2009CA2723185A1 Inhibitors of protein kinases
10/29/2009CA2722345A1 1-aryl-3-aminoalkoxy pyrazoles as sigma ligands enhancing analgesic effect of opioids and attenuating the dependency thereof
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2722065A1 Use of deuterium oxide as an elastase inhibitor
10/29/2009CA2722041A1 Novel five-membered ring compound
10/29/2009CA2722007A1 Five-membered ring compound
10/29/2009CA2720994A1 Therapeutic use of botulinum neurotoxin in the treatment of pain associated with diabetic neuropathy
10/29/2009CA2720357A1 Fused pyrimidineone compounds as trpv3 modulators
10/28/2009EP2112166A2 Human monoclonal antibodies to CTLA-4
10/28/2009EP2112165A2 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
10/28/2009EP2112140A1 Chinazolin derivatives, medicine containing these compounds, application thereof and method for their production
10/28/2009EP2111861A1 Compositions of phosphodiesterase type IV inhibitors
10/28/2009EP2111860A1 Inflammation inhibitor comprising zinc salt of acylamino acid
10/28/2009EP2111395A1 New phenyl- (4-phenyl-pyrimidin-2-yl) - amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
10/28/2009EP2111228A2 Vegf pathway blockade
10/28/2009EP1620182B1 Methods for treating sinus headache
10/28/2009EP1548032B9 Kdr peptides and vaccines comprising the same
10/28/2009EP1503800B1 Treatment and prevention of tissue damage associated with increased c-reactive protein production
10/28/2009EP1379504B1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/28/2009EP1371377B1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
10/28/2009EP1181047B2 Composition comprising alkaline sphingomyelinase of bacterial origin for use as a dietetic preparation, food supplement or pharmaceutical product
10/28/2009EP1150666B1 Gm-csf for the treatment of crohn's disease
10/28/2009EP1098908B1 Anti-ccr2 antibodies and methods of use therefor
10/28/2009CN101568330A Methods for the preparation of biologically active compounds in nanoparticulate form
10/28/2009CN101565423A Thienopyridine derivatives, production method and use thereof
10/28/2009CN101565420A LIMK2 inhibitors, compositions comprising them, and methods of their use
10/28/2009CN101565411A Method for extracting fucoxanthin from brown algae
10/28/2009CN101565404A Heterocyclic compounds
10/28/2009CN101564522A Chinese medicament for treating intercostal nerve pain and preparation method thereof
10/28/2009CN101564514A Method for analyzing children Fengreqing particle
10/28/2009CN101564501A Big activating collateral preparation and preparation method thereof
10/28/2009CN101564485A Chinese herbal medicine formula for curing sciatic neuralgia and preparation method thereof
10/28/2009CN101564477A Small activating collateral preparation and preparation method thereof
10/28/2009CN101564443A Chinese medicament for treating intravenous injection extravasation bruising
10/28/2009CN101564436A Method for separating and extracting lipo-alkaloids in Radix Aconiti Kusnezoffi class of traditional Mongolian medicine
10/28/2009CN101564435A Concocting method for Mongolian medicinal material monkshood
10/28/2009CN101564433A Chinese medicinal composition for treating rheumatic diseases, and preparation method thereof
10/28/2009CN101564424A Common lamiophlomis root chewable tablet and preparation thereof
10/28/2009CN101564415A Chinese medicine microemulsion preparation with enhanced percutaneous permeability and preparation method thereof
10/28/2009CN101564387A Oral arginine ibuprofen liquid preparation
10/28/2009CN101564383A Skin external used patch
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/28/2009CN100554260C Fukinanolide compounds and pharmaceutical application thereof
10/28/2009CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/28/2009CN100553646C Use of probiotic lactic acid bacteria for balancing the skin's immune system
10/28/2009CN100553636C Method of using diketopiperazines and composition containing them
10/28/2009CN100553633C Injectable long-acting analgesic composition comprising an ester derivative of ketorolac
10/28/2009CN100553624C 'Duyiwei' soft capsule and its preparation
10/28/2009CN100553614C Preparation method of quickly disintegrating and dissolving solid medicine composition for oral cavity and its tablet
10/28/2009CN100553611C Injection for treating rheumatoid disease
10/27/2009US7608718 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity
10/27/2009US7608716 Pyrazolonaphthyridine derivative
10/27/2009US7608691 Antibodies against IL-16 antagonist peptides
10/27/2009US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules
10/27/2009US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009US7608634 Substituted pyrrolines as kinase inhibitors
10/27/2009US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009US7608618 1-(2,2,2-trifluoroethanoyl)pyrrolidine-2-carboxylic acid [4-methoxy-3-(3-pyrazin-2-yl-ureido)phenyl]-amide; 4-Methoxy-N-(3-methylamino-propyl)-3-(3-pyrazin-2-yl-ureido)-benzamide; checkpoint kinase Chk1 inhibitor; chemosensitizing agents useful in the treatment of diseases related to DNA damage
10/27/2009US7608577 Peptidyl ketones as inhibitors of DPIV
10/27/2009US7608452 Polynucleotides encoding cytokine receptor zcytor19
10/27/2009US7608411 Prostaglandin receptor EP1
10/27/2009US7608284 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
10/27/2009US7608253 end-capped polyethylene glycol carbamate derivatives useful as water-soluble pro-drugs; controll hydrolytic degradation of hydrogels; conjugate polymer drug for controlled release
10/27/2009US7608245 Transmission and, or amplification of signal ; oral or enteric administering; dissolving; absorption by small inteestines; peptide yy; obesity therapy
10/27/2009CA2536870C Phenyl or pyridyl amide compounds as prostaglandin e2 antagonists
10/27/2009CA2477019C Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
10/27/2009CA2466724C Benzamide and heteroarylamide as p2x7 receptor antagonists
10/27/2009CA2432713C Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
10/27/2009CA2422210C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2421826C Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
10/27/2009CA2419665C Novel 2-phenylpiperazine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009CA2376355C N-heterocyclic derivatives as nos inhibitors
1 ... 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 ... 1272